STOK icon

Stoke Therapeutics

96 hedge funds and large institutions have $372M invested in Stoke Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 34 increasing their positions, 40 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-11
Holders Change %
-10.28%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
5
Increased
34
Reduced
40
Closed
16
Calls
$120K
Puts
$14K
Net Calls
+$106K
Net Calls Change
-$36K
Name Holding Trade Value Shares
Change
Shares
Change %
Acadian Asset Management
101
Acadian Asset Management
Massachusetts
-$711K -77,194 Closed
Two Sigma Advisers
102
Two Sigma Advisers
New York
-$338K -36,600 Closed
Balyasny Asset Management
103
Balyasny Asset Management
Illinois
-$268K -29,038 Closed
Victory Capital Management
104
Victory Capital Management
Texas
-$172K -18,581 Closed
JF
105
Jump Financial
Illinois
-$144K -15,552 Closed
Rafferty Asset Management
106
Rafferty Asset Management
New York
-$133K -14,429 Closed
LCM
107
Landscape Capital Management
New Jersey
-$129K -13,936 Closed
Simplex Trading
108
Simplex Trading
Illinois
-$98K -10,658 Closed
CS
109
Credit Suisse
Switzerland
-$91K -9,859 Closed
QT
110
Quantbot Technologies
New York
-$30.4K -3,291 Closed
PMEF
111
Point72 Middle East FZE
United Arab Emirates
-$15.9K -1,721 Closed
ACM
112
Aquatic Capital Management
Illinois
-$1K -100 Closed
NA
113
NewEdge Advisors
Louisiana
-$692 -75 Closed